The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Mechanisms and Treatment of CKD
Open accessAbstract
As CKD continues to increase worldwide, along with the demand for related life-saving therapies, the financial burden of CKD will place an increasing drain on health care systems. Experimental studies showed that glomerular capillary hypertension and impaired sieving function with consequent protein overload play a pathogenic role in the progression of CKD. Consistently, human studies show that proteinuria is an independent predictor of progression and that its reduction is renoprotective. At comparable BP control, inhibitors of the renin-angiotensin system (RAS), including angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), more effectively than non-RAS inhibitor therapy reduce proteinuria, slow progression to ESRD, and even improve the kidney function achieving disease regression in some cases. In participants with diabetes, RAS inhibitors delay the onset of microalbuminuria and its progression to macroalbuminuria, and ACE inhibitors may reduce the excess cardiovascular mortality associated with diabetic renal disease. In addition to RAS inhibitors, however, multimodal approaches including lifestyle modifications and multidrug therapy will be required in most cases to optimize control of the several risk factors for CKD and related cardiovascular morbidity. Whether novel medications may help further improve the cost-effectiveness of renoprotective interventions is a matter of investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Self-citationThe effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Parving, H.-H., Lehnert, H., Bröchner-Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011489 · Cited by 2,873
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
Pfeffer, M. A., Burdmann, E. A., Chen, C.-Y., Cooper, M. E., de Zeeuw, D., Eckardt, K.-U., Feyzi, J. M., Ivanovich, P., Kewalramani, R., Levey, A. S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907845 · Cited by 2,096
Self-citationMaschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation
Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A., & Brenner, B. M. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.241.1.f85 · Cited by 1,680
Mann, J. F., Schmieder, R. E., McQueen, M., Dyal, L., Schumacher, H., Pogue, J., Wang, X., Maggioni, A., Budaj, A., Chaithiraphan, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61236-2 · Cited by 1,589
Longitudinal Studies on the Rate of Decline in Renal Function with Age
Lindeman, R. D., Tobin, J., & Shock, N. W. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07117.x · Cited by 1,578
Levey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516
Peterson, J. C., Adler, S., Burkart, J. M., Greene, T., Hebert, L. A., Hunsicker, L. G., King, A. J., Klahr, S., Massry, S. G., Seifter, J. L., et al. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-10-199511150-00003 · Cited by 1,342
Pathophysiology of Progressive Nephropathies
Remuzzi, G., & Bertani, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811123392007 · Cited by 1,269
Self-citationZatz, R., Dunn, B. R., Meyer, T. W., Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112521 · Cited by 1,209
Reversal of Lesions of Diabetic Nephropathy after Pancreas Transplantation
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C., & Mauer, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807093390202 · Cited by 1,135
Aliskiren Combined with Losartan in Type 2 Diabetes and Nephropathy
Parving, H.-H., Persson, F., Lewis, J. B., Lewis, E. J., & Hollenberg, N. K. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708379 · Cited by 1,098
Anderson, S., Rennke, H. G., & Brenner, B. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112528 · Cited by 1,072
Preventing Microalbuminuria in Type 2 Diabetes
Ruggenenti, P., Fassi, A., Ilieva, A. P., Bruno, S., Iliev, I. P., Brusegan, V., Rubis, N., Gherardi, G., Arnoldi, F., Ganeva, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042167 · Cited by 1,020
Self-citationde Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Self-citationRuggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910
Self-citationAngiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy
Barnett, A. H., Bain, S. C., Bouter, P., Karlberg, B., Madsbad, S., Jervell, J., & Mustonen, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042274 · Cited by 910
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pergola, P. E., Raskin, P., Toto, R. D., Meyer, C. J., Huff, J. W., Grossman, E. B., Krauth, M., Ruiz, S., Audhya, P., Christ-Schmidt, H., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105351 · Cited by 890
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
Liu, Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121226 · Cited by 870
Mechanisms of Tubulointerstitial Fibrosis
Zeisberg, M., & Neilson, E. G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080793 · Cited by 868
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Haller, H., Ito, S., Izzo, J. L., Januszewicz, A., Katayama, S., Menne, J., Mimran, A., Rabelink, T. J., Ritz, E., Ruilope, L. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1007994 · Cited by 792
How Does Proteinuria Cause Progressive Renal Damage?
Abbate, M., Zoja, C., & Remuzzi, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040377 · Cited by 779
Self-citationEfficacy and Safety of Benazepril for Advanced Chronic Renal Insufficiency
Hou, F. F., Zhang, X., Zhang, G. H., Xie, D., Chen, P. Y., Zhang, W. R., Jiang, J. P., Liang, M., Wang, G. B., Liu, Z. R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053107 · Cited by 710
de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H.-H., Pritchett, Y., Remuzzi, G., Ritz, E., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61032-x · Cited by 695
Self-citationRuggenenti, P., Perna, A., Loriga, G., Ganeva, M., Ene-Iordache, B., Turturro, M., Lesti, M., Perticucci, E., Chakarski, I. N., Leonardis, D., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71082-5 · Cited by 644
Self-citationNephron adaptation to renal injury or ablation
Brenner, B. M. (1985) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1985.249.3.f324 · Cited by 641
Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes
Remuzzi, G. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27699 · Cited by 618
Self-citationRuggenenti, P., Perna, A., Gherardi, G., Gaspari, F., Benini, R., & Remuzzi, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04433-x · Cited by 574
Self-citationProgression, remission, regression of chronic renal diseases
Ruggenenti, P., Schieppati, A., & Remuzzi, G. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04728-0 · Cited by 554
Self-citationZatz, R., Meyer, T. W., Rennke, H. G., & Brenner, B. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5963 · Cited by 526
Pedrini, M. T., Levey, A. S., Lau, J., Chalmers*, T. C., & Wang, P. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00002 · Cited by 496
Avosentan for Overt Diabetic Nephropathy
Mann, J. F. E., Green, D., Jamerson, K., Ruilope, L. M., Kuranoff, S. J., Littke, T., & Viberti, G. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060593 · Cited by 492
Statins for Improving Renal Outcomes: A Meta-Analysis
Sandhu, S., Wiebe, N., Fried, L. F., & Tonelli, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010012 · Cited by 478
The Modification of Diet in Renal Disease Study
Klahr, S. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903303201310 · Cited by 454
Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
Taal, M. W., & Brenner, B. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00031.x · Cited by 439
Pulsatile pressures in the microcirculation of frog's mesentery
Wiederhielm, C. A., Woodbury, J. W., Kirk, S., & Rushmer, R. F. (1964) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1964.207.1.173 · Cited by 439
Ruggenenti, P., Nefrologia”(GISEN), O. B. O. T. “. I. D. S. E. I., Perna, A., Mosconi, L., Pisoni, R., & Remuzzi, G. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00874.x · Cited by 434
Self-citationMyofibroblast differentiation during fibrosis: role of NAD(P)H oxidases
Barnes, J. L., & Gorin, Y. (2011) · Kidney International · doi:10.1038/ki.2010.516 · Cited by 432
Renal protective effect of enalapril in diabetic nephropathy.
Bjorck, S., Mulec, H., Johnsen, S. A., Norden, G., & Aurell, M. (1992) · BMJ · doi:10.1136/bmj.304.6823.339 · Cited by 432
Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
Remuzzi, G., & Bertani, T. (1990) · Kidney International · doi:10.1038/ki.1990.217 · Cited by 397
Self-citationUpadhyay, A., Earley, A., Haynes, S. M., & Uhlig, K. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-8-201104190-00335 · Cited by 340
Mahajan, A., Simoni, J., Sheather, S. J., Broglio, K. R., Rajab, M. H., & Wesson, D. E. (2010) · Kidney International · doi:10.1038/ki.2010.129 · Cited by 339
Pirfenidone for Diabetic Nephropathy
Sharma, K., Ix, J. H., Mathew, A. V., Cho, M., Pflueger, A., Dunn, S. R., Francos, B., Sharma, S., Falkner, B., McGowan, T. A., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101049 · Cited by 319
Durvasula, R. V., Petermann, A. T., Hiromura, K., Blonski, M., Pippin, J., Mundel, P., Pichler, R., Griffin, S., Couser, W. G., & Shankland, S. J. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00362.x · Cited by 313
Sodium Intake, ACE Inhibition, and Progression to ESRD
Vegter, S., Perna, A., Postma, M. J., Navis, G., Remuzzi, G., & Ruggenenti, P. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011040430 · Cited by 305
Self-citationHemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension.
Dworkin, L. D., Hostetter, T. H., Rennke, H. G., & Brenner, B. M. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111349 · Cited by 282
Retarding progression of chronic renal disease: The neglected issue of residual proteinuria
Ruggenenti, P., Perna, A., Remuzzi, G., & Investigators of the Gisen Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00033.x · Cited by 279
Self-citationChrysostomou, A., & Becker, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451215 · Cited by 267
Remuzzi, A., Puntorieri, S., Battaglia, C., Bertani, T., & Remuzzi, G. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114470 · Cited by 259
Self-citationAgeing and the glomerular filtration rate: truths and consequences.
Glassock, R. J., & Winearls, C. G. (2009) · PubMed Central · Cited by 251
Hou, F. F., Xie, D., Zhang, X., Chen, P. Y., Zhang, W. R., Liang, M., Guo, Z. J., & Jiang, J. P. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121372 · Cited by 251
for the ORIENT study investigators, Imai, E., Chan, J. C. N., Ito, S., Yamasaki, T., Kobayashi, F., Haneda, M., & Makino, H. (2011) · Diabetologia · doi:10.1007/s00125-011-2325-z · Cited by 236
Kohan, D. E., Pritchett, Y., Molitch, M., Wen, S., Garimella, T., Audhya, P., & Andress, D. L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080869 · Cited by 236
Protein restriction for diabetic renal disease
Robertson, L. M., Waugh, N., & Robertson, A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002181.pub2 · Cited by 234
Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis
Cho, M. E., Smith, D. C., Branton, M. H., Penzak, S. R., & Kopp, J. B. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01050207 · Cited by 222
Ruggenenti, P., Perna, A., & Remuzzi, G. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122832 · Cited by 220
Self-citationShort- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes.
Remuzzi, A., Perico, N., Amuchastegui, C. S., Malanchini, B., Mazerska, M., Battaglia, C., Bertani, T., & Remuzzi, G. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v4140 · Cited by 218
Self-citationCELLULAR MECHANISMS OF PROTEIN METABOLISM IN THE NEPHRON
Oliver, J., MacDowell, M., & Lee, Y. C. (1954) · Journal of Experimental Medicine · doi:10.1084/jem.99.6.589 · Cited by 215
Angiotensin receptor blockers and myocardial infarction
Verma, S., & Strauss, M. (2004) · BMJ · doi:10.1136/bmj.329.7477.1248 · Cited by 210
Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition
Zoccali, C., Ruggenenti, P., Perna, A., Leonardis, D., Tripepi, R., Tripepi, G., Mallamaci, F., & Remuzzi, G. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011020175 · Cited by 210
Self-citationRole of Remission Clinics in the Longitudinal Treatment of CKD
Ruggenenti, P., Perticucci, E., Cravedi, P., Gambara, V., Costantini, M., Sharma, S. K., Perna, A., & Remuzzi, G. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007090970 · Cited by 204
Self-citationGambaro, G., Kinalska, I., Oksa, A., Pont’uch, P., Hertlová, M., Olsovsky, J., Manitius, J., Fedele, D., Czekalski, S., Perusicová, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014254.87188.e5 · Cited by 192
Campbell, R., Sangalli, F., Perticucci, E., Aros, C., Viscarra, C., Perna, A., Remuzzi, A., Bertocchi, F., Fagiani, L., Remuzzi, G., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00832.x · Cited by 188
Self-citationRUGGENENTI, P., PERNA, A., BENINI, R., BERTANI, T., ZOCCALI, C., MAGGIORE, Q., SALVADORI, M., & REMUZZI, G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v105997 · Cited by 186
Self-citationRuggenenti, P., Perna, A., Gherardi, G., Benini, R., & Remuzzi, G. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70054-0 · Cited by 176
Self-citationSerial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
Fogo, A., Yoshida, Y., Glick, A. D., Homma, T., & Ichikawa, I. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113590 · Cited by 175
Treatment of chronic kidney disease
Turner, J. M., Bauer, C., Abramowitz, M. K., Melamed, M. L., & Hostetter, T. H. (2012) · Kidney International · doi:10.1038/ki.2011.380 · Cited by 172
Abbate, M., Zoja, C., Morigi, M., Rottoli, D., Angioletti, S., Tomasoni, S., Zanchi, C., Longaretti, L., Donadelli, R., & Remuzzi, G. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64495-1 · Cited by 170
Self-citationHow To Fully Protect the Kidney in a Severe Model of Progressive Nephropathy: A Multidrug Approach
Zoja, C., Corna, D., Camozzi, D., Cattaneo, D., Rottoli, D., Batani, C., Zanchi, C., Abbate, M., & Remuzzi, G. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000034912.55186.ec · Cited by 167
Self-citationKent, D. M., Jafar, T. H., Hayward, R. A., Tighiouart, H., Landa, M., de Jong, P., de Zeeuw, D., Remuzzi, G., Kamper, A.-L., & Levey, A. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101081 · Cited by 162
Self-citationOverview of factors contributing to the pathophysiology of progressive renal disease
Schlondorff, D. O. (2008) · Kidney International · doi:10.1038/ki.2008.351 · Cited by 158
ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria
Mallamaci, F., Ruggenenti, P. L., Perna, A., Leonardis, D., Tripepi, R., Tripepi, G., Remuzzi, G., & Zoccali, C. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090969 · Cited by 158
Self-citationParacrine stimulation of human renal fibroblasts by proximal tubule cells
Johnson, D. W., Saunders, H. J., Baxter, R. C., Field, M. J., & Pollock, C. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00048.x · Cited by 140
Apperloo, A. J., de Zeeuw, D., & de Jong, P. E. (1994) · PubMed · Cited by 138
Structural and Functional Adaptation in Renal Failure.--II
Platt, R. (1952) · BMJ · doi:10.1136/bmj.1.4773.1372 · Cited by 133
Holtkamp, F. A., de Zeeuw, D., de Graeff, P. A., Laverman, G. D., Berl, T., Remuzzi, G., Packham, D., Lewis, J. B., Parving, H. ‐., & Heerspink, H. J. L. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr017 · Cited by 132
Self-citationRemuzzi, G., Ruggenenti, P., Perna, A., Dimitrov, B. D., de Zeeuw, D., Hille, D. A., Shahinfar, S., Carides, G. W., & Brenner, B. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000146423.71226.0c · Cited by 123
Self-citationImaging of the Porous Ultrastructure of the Glomerular Epithelial Filtration Slit
Gagliardini, E., Conti, S., Benigni, A., Remuzzi, G., & Remuzzi, A. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020199 · Cited by 119
Self-citationRemuzzi, A., Gagliardini, E., Sangalli, F., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000060 · Cited by 118
Chronic Kidney Disease in Cancer Patients: An Independent Predictor of Cancer-Specific Mortality
Na, S. Y., Sung, J. Y., Chang, J. H., Kim, S., Lee, H. H., Park, Y. H., Chung, W., Oh, K., & Jung, J. Y. (2011) · American Journal of Nephrology · doi:10.1159/000323740 · Cited by 113
Present and future drug treatments for chronic kidney diseases: evolving targets in renoprotection
Perico, N., Benigni, A., & Remuzzi, G. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2685 · Cited by 108
Self-citationRuggenenti, P. L., Perna, A., Mosconi, L., Matalone, M., Pisoni, R. L., Gaspari, F., & Remuzzi, G. (1997) · PubMed · Cited by 106
Self-citationTylicki, L., Rutkowski, P., Renke, M., Larczyński, W., Aleksandrowicz, E., Łysiak−Szydłowska, W., & Rutkowski, B. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.297 · Cited by 104
Podocyte Repopulation Contributes to Regression of Glomerular Injury Induced by Ace Inhibition
Macconi, D., Sangalli, F., Bonomelli, M., Conti, S., Condorelli, L., Gagliardini, E., Remuzzi, G., & Remuzzi, A. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080227 · Cited by 101
Self-citationRemission of renal disease: recounting the challenge, acquiring the goal
Brenner, B. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci17351 · Cited by 93
Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Rossing, P. R., Hommel, E. E., Smidt, U. M., & Parving, H. ‐. (1994) · PubMed · Cited by 93
Ruggenenti, P. L., Fassi, A., Parvanova, A. I., Iliev, I. P., Chiurchiu, C. R., Rubis, N., Gherardi, G., Ene‐Iordache, B., Gaspari, F., Perna, A., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834069bd · Cited by 85
Self-citationIbrahim, H. N., Rosenberg, M. E., & Hostetter, T. H. (1997) · PubMed · Cited by 57
Blè, A., Mosca, M., Loreto, G. D., Guglielmotti, A., Biondi, G., Bombardieri, S., Remuzzi, G., & Ruggenenti, P. L. (2011) · American Journal of Nephrology · doi:10.1159/000330685 · Cited by 52
Self-citationThe role of renin angiotensin system inhibition in kidney repair
van der Meer, I. M., Cravedi, P., & Remuzzi, G. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-7 · Cited by 52
Self-citationProteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies
Ruggenenti, P., Perna, A., Mosconi, L., Matalone, M., Pisoni, R., Gaspari, F., & Remuzzi, G. (1997) · Kidney International · Cited by 50
Self-citationRuggenenti, P. L., Perna, A., Tonelli, M. A., Loriga, G., Motterlini, N., Rubis, N., Ledda, F., Rota, S., Satta, A. E., Granata, A. R. M., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03380410 · Cited by 48
Self-citationBenigni, A., Gagliardini, E., & Remuzzi, G. (2004) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2003.11.005 · Cited by 47
Self-citationIs the ONTARGET renal substudy actually off target?
Ruggenenti, P. L., & Remuzzi, G. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.109 · Cited by 45
Self-citationRuggenenti, P. L., Brenner, B. M., & Remuzzi, G. (2001) · The Nephron journals/Nephron journals · doi:10.1159/000045998 · Cited by 41
Self-citationProteinuria: an ignored marker of inflammation and cardiovascular disease in chronic hemodialysis
Trimarchi, H., Muryan, Dicugno, Young, P., Forrester, Lombi, Pomeranz, Iriarte, Rana, M., & Alonso (2011) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s27675 · Cited by 28
Adarkwah, C. C., Gandjour, A., Akkerman, M. K., & Evers, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026139 · Cited by 27
Which antihypertensive drugs are the most nephroprotective and why?
Cravedi, P., Ruggenenti, P. L., & Remuzzi, G. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.521742 · Cited by 24
Self-citationThe Remission Clinic approach to halt the progression of kidney disease
(2011) · Journal of Nephrology · doi:10.5301/jn.2011.7763 · Cited by 22
Non-immune interventions to protect kidney allografts in the long term
Cravedi, P., Perico, N., & Remuzzi, G. (2010) · Kidney International · doi:10.1038/ki.2010.427 · Cited by 20
Self-citationTargeting the Renin Angiotensin System in Dialysis Patients
Cravedi, P., Remuzzi, G., & Ruggenenti, P. L. (2011) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2011.00939.x · Cited by 19
Self-citationAldosterone in clinical nephrology--old hormone, new questions
Becker, G. J., Hewitson, T. D., & Chrysostomou, A. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp256 · Cited by 13
Cited by
Bikbov, B., Purcell, C. A., Levey, A. S., Smith, M., Abdoli, A., Abebe, M., Adebayo, O. M., Afarideh, M., Agarwal, S. K., Agudelo-Botero, M., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30045-3 · Cited by 6,648
Self-citationRomagnani, P., Remuzzi, G., Glassock, R., Levin, A., Jager, K. J., Tonelli, M., Massy, Z., Wanner, C., & Anders, H.-J. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.88 · Cited by 996
Self-citationMicroRNAs in kidney physiology and disease
Trionfini, P., Benigni, A., & Remuzzi, G. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.202 · Cited by 353
Self-citationRediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases
Argyropoulos, C. P., Chen, S. S., Ng, Y.-H., Roumelioti, M.-E., Shaffi, K., Singh, P. P., & Tzamaloukas, A. H. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00073 · Cited by 308
Molecules Great and Small: The Complement System
Mathern, D. R., & Heeger, P. S. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06230614 · Cited by 290
Metadata
- Authors
- Ruggenenti, P., Cravedi, P., & Remuzzi, G.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-12
- Volume
- 23
- Issue
- 12
- Pages
- 1917-1928
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2124602789
- Cited by
- 286
- References
- 110
- FWCI
- 16.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.